Index

Acceptance and commitment therapy (ACT), for intervention of SUDs and CSB,

22, 27

ACT

. See Acceptance and commitment therapy

Addictions

features of,

16

inclusions of,

13

ADHD

. See Attention-deficit hyperactivity disorder

Adisex Project,

43

Adolescents

online CSB and,

3–40

onset of HD,

69–70

sexual behavior in,

26

Aggravating factors, description of,

154–155

Alcohol abuse, association with CSBD,

83

Alkyl nitrites, association with CSBD,

82

American Hospital Association,

67

Amphetamine/dextroamphetamine, association with CSBD,

82

Antidepressants

association with CSBD,

82

for treatment of hypersexuality,

158

Anxiety, association with CSBD,

80, 80, 82

Art therapy for treatment of CSB in women,

136

At-risk sexual addiction (SAST-R),

25

Attachment, association with CSBD,

80, 80

Attention-deficit hyperactivity disorder (ADHD), association with CSBD,

80

Autoerotic activity,

xiii

Ayurvedic medicine,

182

“Barebackers,”

173

Beck Depression Inventory–II,

42

Behavior

. See also Compulsive sexual behavior; Hypersexuality; Sexual behavior

classification of,

4

patient’s history of,

76

promiscuous,

xiii

sensation seeking,

168–170

sexual impulsivity,

22

Behavioral addiction,

8

Behavioral analysis,

117. See also Psychotherapy, for treatment of CSBD

Behavior cycle,

117–118. See also Psychotherapy, for treatment of CSBD

Boundaries

development,

114–116

resistance to,

124

of sexual behavior,

114–116

Bupropion, association with CSBD,

82

Caffeine pills, association with CSBD,

82

Canada, role of hypersexuality in courts,

150–152

Cannabis

abuse of,

24–25

CSB and,

26

lifetime use of,

26

Carnes, P., SA criteria,

73, 75

Case examples

. See also Patients

of chain analysis,

123

of CSB in women,

137–138

of CSBD,

88, 89

with paraphilic disorders,

103–104

of developing a healthy relationship to sexuality and intimacy,

120–121

of legal issues with HD,

146, 148

of online sexual activities,

37–38

of pornography,

12

of psychotherapy,

120–126

of religious and cultural influences of CSBD,

183–188

of risky sexual behavior,

174–175

of SA,

87–89

of sexual addiction,

12

of sexual compulsivity,

183–188

of Sexual Dependency Inventory scale of consequences,

89

of sexual disorder not otherwise specified,

62–63

of substance use disorder with CSB,

28–30

Case law

Daubert v. Merrell Dow Pharmaceuticals Inc.,

160, 161

Frye v. United States,

160

R. v. J. (L.-J.),

160–161

R. v. Mohan,

160–161

Castration,

159

Catherine the Great,

181

CBT

. See Cognitive-behavioral therapy

Centers for Medicare and Medicaid Services,

61

Chain analysis,

117. See also Psychotherapy, for treatment of CSBD

case example of,

123

Child molesters,

156

China, sensation seeking behavior study in,

171

Chinese Classification of Mental Disorders,

54

Cisgender individual,

122, 124

Clinical interview, for CSBD,

73–79, 78

Cocaine, association with CSBD,

83

Cognitive-behavioral therapy (CBT)

for intervention of SUDs and CSB,

22

for treatment of CSB in men,

186

for treatment of CSB in women,

136

for treatment of hypersexuality,

157

for treatment of SUDs with CSB,

27–28

Compulsive sexual behavior (CSB)

. See also Diagnostic and Statistical Manual; International Classification of Diseases

description of,

22–23

environment and,

41–42

with gambling disorder,

22

treatment recommendations,

7

intervention with CBT,

22

rates of co-occurrence of,

14

self-reported impulsivity,

14

SSRIs for treatment of,

98

with SUDs

cannabis use and,

26

case examples of,

28–30

future directions,

30–31

overview,

21–22

prevalence of,

23–26

rates of,

21–22

research,

22

in special populations,

26–27

treatment recommendations,

27–28

intervention with CBT,

22

Compulsive sexual behavior disorder (CSBD)

. See also Diagnostic and Statistical Manual; International Classification of Diseases; Women

as autoerotic activity,

xiii

case examples of,

89, 88

characterization of,

37–38, 109–110

clinical assessment of clinical interview,

73–79, 78

overview,

73

clinical criteria for case examples of,

88, 89

definitions of,

22

in ICD-11,

110

description of,

70–71

diagnosis of,

2

Oxford English Dictionary definition of,

54

diagnostic guidelines for,

11–12

disorders commonly presenting with,

79–81, 79

dual control model of,

95, 96

features of,

11, 11

field trials for,

5

as impulse-control disorder,

13–15

inclusion in ICD-11,

69–70

medical testing and,

81–83, 82

medicine and, Oxford English Dictionary definition of,

54

mental health problems commonly associated with,

80

nonparaphilic,

8

online sexual activities

assessment methods,

41–42

case example of,

37–38

description of,

35–36, 36

development of,

39–41

Internet and,

37–39

risk profile of,

39

sexual abuse and,

41

traits and,

40

stigma of,

43

treatment

biological,

42

psychological,

43–47

techniques for,

44

overview,

10–12

pattern of,

44–45

prevalence of,

22

females versus males,

13–14

psychometrics,

83, 84–86, 87–90

religious and cultural influences of,

179–189

treatment

dopamine replacement therapies,

15

modalities,

111

pharmacotherapy,

95–108

psychotherapies,

109–128

umbrella structure of,

95–96

World Health Organization

approach to,

xi

approval of inclusion in ICD-11,

10–11

Compulsive Sexual Behavior Disorder–19 (CSBD-19),

12

Compulsive Sexual Behavior Inventory (CSBI-13),

12, 83, 84

Corticosteroids, association with CSBD,

82

Crystal methamphetamine, association with CSBD,

83

CSB

. See Compulsive sexual behavior

CSBD

. See Compulsive sexual behavior disorder

Cuban Glossary of Psychiatry,

54

Culture

. See also Religion

Don Juanism,

180–181

expectations about gender roles,

134

influence on CSBD

case examples of,

183–188

history and,

180–183

overview,

179–180

leathermen subculture,

172–173

sexual mores,

187

social context that interacts with CSB in women,

134

socialization in conservative sexual culture,

40–41

Cyber-Pornography Use Inventory–9,

42

Cybersex,

39, 40. See also Online sexual activities

Cyproterone acetate (CPA)

adverse reactions to,

98–99

double-blind studies of,

98

GnRH and,

98

LH and,

98

for treatment of patients with CSBD,

98–99, 105

Daubert v. Merrell Dow Pharmaceuticals Inc.,

160, 161

Denial,

76–77

Depo-Provera

. See Medroxyprogesterone acetate

Depression, association with CSBD,

80, 80, 82

Deviant, description of,

110

DHA

. See Docosahexaenoic acid

Dhat syndrome,

182–183

Docosahexaenoic acid (DHA), association with CSBD,

82

Don Juanism,

180–181

Dopamine

association with CSBD,

82

for treatment of CSBD,

15

DSM

comparison with ICD,

61, 62

DSM-I through DSM-IV-TR

category of “sexual deviation,”

57

category of “unspecified sexual deviation,”

57

DSM-5

alternative proposed diagnostic criteria for other specified mental disorder,

60–61

category of “other specified disruptive, impulse-control, and conduct disorder,”

59–60

category of “other specified sexual dysfunction,”

59

category of “unspecified sexual dysfunction,”

59

developmental stages of HD,

143–144

diagnostic criteria for HD,

2

Paraphilic Disorders Subcommittee,

57–58

proposed criteria for sexual addiction,

9

proposed diagnostic criteria for HD,

58, 58–59, 72

Task Force,

10

Work Group on Sexual and Gender Identity Disorders,

4, 10, 57–58

DSM-III

category and definition of psychosexual disorder not elsewhere classified,

57

DSM-III-R

category of sexual disorder not otherwise specified,

57

DSM-IV

category of sexual disorder not otherwise specified,

57

DSM-IV-TR

definitions for diagnosis of CSBD,

54

history of,

64–65

Environment, CSB and,

41–42

Erectile dysfunction

association with CSBD,

80

cultural and religious influence on,

186

OSA and,

40

Erectogenics, association with CSBD,

82

Erotomania,

59, 181–182

Exhibitionism,

102

Expert witness role in legal realm,

160–161

Exposure-response prevention, for treatment of OSA,

44

Family, inclusion in treatment of CSBD,

112

Field trials

for CSBD,

5

for HD,

4

Finasteride, for treatment of hypersexuality,

158

Fluoxetine, for treatment of CSBD,

98, 186

French Classification of Child and Adolescent Mental Disorders,

54

Frigidity, in women,

129–130

Frye v. United States,

160

Functional analysis,

117. See also Psychotherapy, for treatment of CSBD

Gambling disorder,

24

with SUDs and CSB,

22

Gender, cultural expectations of,

134

Ginkgo biloba, association with CSBD,

82

GnRH agonists

. See Gonadotropin-releasing hormone

description of,

100–101

side effects of,

101

for treatment of patients with CSBD,

100–101, 106

Gonadotropin-releasing hormone (GnRH), CPA and,

98

Good Lives Model,

159

Goodman, A., SA criteria,

73, 74

Great Britain, hypersexuality survey in,

172

HBI

. See Hypersexual Behavior Inventory

HD

. See Hypersexual disorder

HDSI

. See Hypersexual Disorder Screening Inventory

Herbals, association with CSBD,

82

Hirschfeld, Magnus,

180

HIV

CSB and,

27

risky behaviors and hypersexuality,

170

Hypersexual Behavior Consequences Scale,

150

Hypersexual Behavior Inventory (HBI),

9, 85

Hypersexual disorder (HD),

8. See also Paraphilias

characterization of,

2

classification of,

3

description of,

71

during developmental stages of DSM-5,

143–144

diagnosis according to Winters,

3

diagnostic criteria for DSM-5,

2

“due to another medical condition,”

149–150

field trials for,

4

Kafka and,

10

model of,

3–4

number of cases of,

4

prevalence of,

69

proposed diagnostic criteria for,

58, 58–59, 71, 72

psychometric measures for,

84–86

symptoms of,

71

Hypersexual Disorder Screening Inventory (HDSI),

83, 133, 85

Hypersexuality

. See also Behavior

“barebackers,”

173

forensic aspects of

applications of hypersexuality in the legal realm

aggravating factors,

154–155

mitigating factors,

153–154

not criminally responsible defense,

152–153

not guilty by reason of insanity defense,

152–153

risk assessment,

155–157

treatment of hypersexuality,

157–160

clinical evaluation in legal settings,

145–147

driving and disinhibiting factors for hypersexual behaviors,

146, 147

psychiatric, neurological, and pharmacological mimics of hypersexuality,

148, 149

expert witness role,

160–161

overview,

143–145

psychiatric and medical mimicry in hypersexual behavior,

147–150

role of hypersexuality in U.S. and Canadian courts,

150–152

standardized measures of hypersexuality in court,

150

in Great Britain,

172

in men,

24

risk-need-responsivity model,

159

sexual compulsivity and overview,

167–168

risk and risky behavior,

168

predominantly nonsexual risky behavior and psychopathology of,

171

predominantly sexual risky behavior,

170–171

sexual sensation seeking,

168–170

sexually transmitted diseases and hypersexuality,

172–174

case example of,

174–175

in Sweden,

171

treatment of,

157–160

Hypoactive sexual desire disorder, ICD-10

diagnostic criteria for,

xi

Hysteria, in women,

129–130

ICD-CM Coordination and Maintenance Committee,

61

Impulse-control disorders,

2, 8. See also Compulsive sexual behavior disorder

category in ICD-11,

70–71

CSBD and,

13–15

self-reported impulsivity,

14

SSRIs for treatment of,

98

susceptibility for development of,

13

International Classification of Diseases

comparison with DSM,

61, 62

history of,

64–65

ICD-6, definition of “pathological sexuality,”

55

ICD-7, definition of “pathological sexuality,”

55

ICD-8, in diagnosis of unspecified sexual deviation,

55

ICD-9

use in diagnosis of CSBD,

54

use in diagnosis of unspecified sexual deviation,

55

ICD-9-CM

use in diagnosis of CSBD,

54

use in diagnosis of unspecified psychosexual disorder,

55

ICD-10

definitions for diagnosis of CSBD,

54

diagnostic criteria for excessive sexual drive,

55

diagnostic criteria for hypoactive sexual desire disorder,

xi

diagnostic criteria for sexual dysfunction not caused by organic disorder or disease,

55

ICD-10-CM, decommissioning of diagnostic code for “excessive sexual drive,”

59

ICD-11

category of impulse-control disorders,

70–71

definition of CSBD,

110

description of paraphilic disorder,

70–71

diagnostic criteria for CSBD,

xi, 2, 11, 56

inclusion of CSBD in,

69–70

“label” of CSBD,

5

World Health Organization approval of inclusion of CSBD in,

10–11

Working Group on Obsessive-Compulsive and Related Disorders,

10–11

Internet

. See Online sexual activities

Internet Sex Screening Test,

42

“Junk science,”

160

Kafka, M.P.,

2–5

HD and,

10

Klüver-Bucy syndrome,

148

Leatherman,

172–173

Legal issues

aggravating factors,

154–155

applications of hypersexuality

aggravating factors,

154–155

mitigating factors,

153–154

not criminally responsible defense,

152–153

not guilty by reason of insanity defense,

152–153

risk assessment,

155–157

treatment of hypersexuality,

157–160

case examples of HD,

146, 148

chemical castration,

159

clinical evaluation of hypersexuality in legal settings,

145–147, 147, 149

court-ordered treatment of sexual disorders,

159

expert witness role,

148, 160–161

irresistible impulse,

153

“junk science,”

160

legal terminology,

153–154

“police office at the elbow test,”

153

prostitutes and,

154

role of hypersexuality in U.S. and Canadian courts,

150–152

standardized measures of hypersexuality in court,

150

surgical castration,

159

Leuprolide

. See also GnRH agonists

for treatment of hypersexuality,

158

Levodopa, association with CSBD,

82

LGBTQ individuals, substance use disorders with CSB and,

31

LH

. See Luteinizing hormone

Likert scale,

133

Lupron

. See GnRH agonists

Luteinizing hormone (LH), CPA and,

98

Mania,

157

Masturbation,

7

MBRP

. See Mindfulness-based relapse prevention

Medroxyprogesterone acetate (MPA; Depo-Provera)

effectiveness of,

99

side effects of,

99–100

for treatment of hypersexuality,

158

for treatment of patients with CSBD,

99–100, 105

Men

addictive behaviors in,

23–24

erectile dysfunction,

40, 80

hypersexuality in,

24

male model as the standard for sexual desire,

135

online CSB,

39

pornography use in,

22–23

premature ejaculation,

80

Men who have sex with men (MSM),

xii

SUDs and CSB in,

26–27

SUDs with CSB,

22

3,4-methylenedioxymethamphetamine, association with CSBD,

83

Methylphenidate

association with CSBD,

82

for treatment of hypersexuality,

158

Mindfulness

for treatment of SUDs with CSB,

28

women and,

23

Mindfulness-based relapse prevention (MBRP), for treatment of SUDs with CSB,

28

Mitigating factors, description of,

153–154

Models

of cybersex,

39

dual control model of CSBD,

95, 96

Good Lives Model,

159

of HD,

3–4

male model as the standard for sexual desire,

135

risk-need-responsivity model,

159

of sexual addiction,

8

Mood and Sexuality Questionnaire,

80

Mood disorders

association with CSBD,

80–81

SUDs and,

25

Motivational interviewing, for treatment of OSA,

43–44

MPA

. See Medroxyprogesterone acetate

MSM

. See Men who have sex with men

Naltrexone

contraindications of,

97

dosage,

97

randomized control trials on behavioral addictions,

97

for treatment of hypersexuality,

158

for treatment of patients with CSBD,

96–97, 105

National Ambulatory Medical Care survey,

60–61

National Center for Health Statistics (NCHS),

61

National Survey of Sexual Attitudes and Lifestyles,

172

NCHS

. See National Center for Health Statistics

NCR

. See Not criminally responsible defense

NGRI

. See Not guilty by reason of insanity defense

Not criminally responsible defense (NCR),

144–145, 152–153

Not guilty by reason of insanity defense (NGRI),

144–145, 148, 152–153

Nymphomania,

59, 129–130. See also Women

description of,

180

history of,

180–181

OCD, SSRIs for treatment of,

98

One-night-stand dating,

16

Online sexual activities (OSA)

abuse of,

46–47

assessment methods,

41–42

Craigslist,

173

description of,

35–36, 36

development of,

39–41

erectile dysfunction and,

40

influence of culture and religion,

188

outcomes of,

36–37

patient’s ambivalence to,

43

prevalence of,

36

risk profile of,

39

sexual abuse and,

41

traits and,

40

treatment

biological,

42

psychological,

43–47

stigma of,

43

techniques for,

44

OSA

. See Online sexual activities

Oxford English Dictionary

definition of diagnosis,

54

definition of medicine,

54

Paliperidone, for treatment of CSBD,

186

Paraphilias,

2, 23. See also Hypersexual disorder

association with CSBD,

80, 81

Paraphilic behavior,

71

Paraphilic disorders,

2

clinical use of drugs to treat CSBD with,

102–103

case example of,

103–104

description in ICD-11,

70–71

PATHOS (Preoccupied, Ashamed, Treatment, Hurts Others, Out of control, Sad) questionnaire,

9

clinical interview and,

76

international validation of,

9–10

Patients

. See also Case examples

ambivalence to OSA,

43

anonymity of treatment for OSA,

43

autobiographical history during psychotherapy,

118–119

generalized life cycle of,

119–120

history of behavior,

76

self-control training for treatment of OSA,

43–44, 46

Perceived Compulsivity,

42

Pharmacotherapy, for patients with CSBD

. See also individual drugs

with GnRH agonists,

100–101

overview,

95–96

psychotherapy and,

101–102

recommendations for clinical use of drugs in patients with CSBD

to enhance sexual self-control or reduce sexual drive,

101–102

proposed algorithm of pharmacological treatment for CSBD,

104, 105–106

to treat comorbid paraphilic disorders,

102–103

case example of,

103–104

to treat comorbid psychiatric disorders,

102

with testosterone-lowering medications,

96–100

cyproterone acetate,

98–99

medroxyprogesterone acetate,

99–100

naltrexone,

96–97

selective serotonin reuptake inhibitors,

97–98

use in core areas,

96

Phosphodiesterase-5 inhibitors, association with CSBD,

82

Poppers, association with CSBD,

82

Pornography

case example of,

12

with men,

22–23

use of,

16

viewing,

36

Pregnancy, unwanted,

133

Premature ejaculation, association with CSBD,

80

Prostitutes,

154

Psychoeducation

. See also Psychotherapy, for treatment of CSBD

for treatment of OSA,

43–44

for women with CSB,

136–138

Psychotherapy, for treatment of CSBD

. See also Psychoeducation

conjoint and couples therapy,

113

group therapy,

112

inclusion of partner and family in treatment,

112

individual therapy,

111–112

modalities,

111, 114

partners’ group therapy,

113–114

proposed algorithm of pharmacological treatment for CSBD,

105–106

treatment process and tasks,

114–122

case examples of,

120–126

developing a healthy relationship to sexuality and intimacy,

120–121

developing boundaries,

114–116

maintenance planning and aftercare,

121–122

stabilization and self-management,

114–118

understanding identity and addressing intimacy concerns,

118–120

autobiographical history,

118–119

generalized life cycle,

119–120

understanding patterns of behavior and developing effective skills,

116–118

Randomized controlled trials (RCTs), with naltrexone for behavioral addictions,

97

Rapists,

155–156

RCTs

. See Randomized controlled trials

Relapse-prevention treatment, for treatment of OSA,

44

Religion

. See also Culture

case examples

of hypersexuality,

63–64

of a sexual disorder not otherwise specified,

62–63

influence on CSBD

overview,

179–180

Risk for Sexual Violence Protocol,

156

Risky sexual behavior,

168

Rivastigmine, for treatment of hypersexuality,

157

Rosenberg Self-Esteem Scale,

42

R. v. J. (L.-J.),

160–161

R. v. Mohan,

160–161

SA

. See Sexual addiction

S-adenosyl methionine (SAM-e), association with CSBD,

82

Salvacyl

. See GnRH agonists

SAM-e

. See S-adenosyl methionine

SAST

. See Sexual Addiction Screening Test

SAST-R

. See At-risk sexual addiction; Sexual Addiction Screening Test–Revised

Satyriasis,

59

description of,

180

history of,

180

SDI

. See Sexual Dependency Inventory

Selective serotonin reuptake inhibitors (SSRIs)

dosage,

98

for treatment of hypersexuality,

158

for treatment of patients with CSBD,

97–98, 105

Self-control training,

46

enhancement of,

101–102

for treatment of OSA,

43–44

Self-esteem, association with CSBD,

80

Sensation seeking behavior,

168–170

in China,

171

in women,

169

Sertraline, for treatment of CSBD,

98

Sex products,

36

Sexting,

16

Sexual abuse, OSA and,

41

Sexual addiction (SA),

8

at-risk individuals,

25

Carnes’ criteria for,

73, 75

case examples of,

12, 87–89

versus CSBD

historical evolution of diagnostic criteria for,

8–10

overview,

7–8

proposed criteria for DSM-5,

9

description of,

71–73

diagnosis of,

71–72

Goodman’s criteria for,

73, 74

mislabeling of “sex addicts,”

151

model,

8

prevalence of,

150–151

proposed diagnostic criteria for,

72

psychometric measures for,

84–86

symptoms of,

8, 71–72

Sexual Addiction Screening Test (SAST),

83, 86, 87

Sexual Addiction Screening Test–Revised (SAST-R),

8–9, 42, 83, 86, 87

international validation of,

9–10

Sexual behavior

in adolescents,

26

boundaries and,

114–116

evolution of,

110–111

loss of control of,

15

out-of-control,

15, 183

preoccupation with,

155–156

“self-soothing” outlet for stress,

157

versus sexual identity,

30

in women,

132

“out of control sexual behavior,”

131

Sexual compulsivity

case examples of,

183–188

description of,

70

hypersexuality and

overview,

167–168

risk and risky behavior,

168

predominantly nonsexual risky behavior and psychopathology,

171

predominantly sexual risky behavior,

170–171

sexual sensation seeking,

168–170

STDs and,

172–174

case example of,

174–175

Sexual Compulsivity Scale,

83, 84, 173

Sexual Dependency Inventory (SDI),

83, 87

case example of,

89

Sexual desire, definition of,

135

Sexual drive,

101–102

Sexual identity

OSA and,

36

versus sexual behavior,

30

Sexual impulsivity, definition of,

22

Sexually transmitted diseases (STDs),

121, 133

association with CSBD,

81

hypersexuality and,

172–175

preventive measures for,

173–174

Sexual orientation, xii

. See also Men who have sex with men

Sexual Sensation Seeking Scale and Sexual Compulsivity Scale,

42

Sexual Violence Risk–20,

156

Sex work,

36

Sildenafil, association with CSBD,

82

Spirituality,

180. See also Culture; Religion

SSRIs

. See Selective serotonin reuptake inhibitors

Stable-2007,

155

State-Trait Anxiety Inventory,

42

STDs

. See Sexually transmitted diseases

Stimulants

association with CSBD,

82

risky sexual behavior and,

170

Structured Clinical Interview for DSM–type interview,

171–172

Substance use disorders (SUDs)

association with CSBD,

80, 80, 82–83

with CSB

cannabis use and,

26

case examples of,

28–30

future directions,

30–31

overview,

21–22

prevalence of,

23–26

rates of,

21–22

research,

22

in special populations,

26–27

treatment recommendations,

27–28

CBT and,

27

intervention with CBT,

22

mood disorders and,

25

SUDs

. See Substance use disorders

Sweden, hypersexuality survey in,

171

Testosterone replacement therapy

. See also Pharmacotherapy, for patients with CSBD

association with CSBD,

82

Tobacco use,

24

Triptorelin

. See also GnRH agonists

for treatment of hypersexuality,

158

United States

military veterans

at-risk for CSB,

27

SUDs with CSB,

22

case examples of,

28–30

role of hypersexuality in courts,

150–152

sexually violent predator laws in,

144–145

Valeria Messalina,

181

Von Krafft-Ebing, Richard,

180, 181

Voyeurism,

102

WHO

. See World Health Organization

Winters, J., diagnosis of HD according to,

3

Women

. See also Nymphomania

art therapy for CSB in women,

136

CBT for treatment of CSB in,

136

CSBD in

overview,

129–130

prevalence of,

131–132

CSB in,

23

assessment of,

133–134

case example of,

137–138

characterization of,

130

clinical implications of,

135–136

clinical interventions,

136–138

“love addicted,”

133

male model as the standard for sexual desire,

135

personality characteristics and comorbidities,

133

psychoeducation,

136–138

sexual behaviors,

132

sexual risk behavior,

132–133

social context of,

134

studies of,

131–132

expectations about gender roles,

134

experiential avoidance and,

25

frigidity in,

129–130

hysteria in,

129–130

mindfulness and,

23

online CSB,

39

sexual desire in,

129–130

sexuality of,

130

sexual sensation seeking in,

169

Women’s Sexual Addiction Screening Test (WSAST),

131–133

Work Group on Sexual and Gender Identity Disorders,

71, 72, 83

Working Group on Obsessive-Compulsive and Related Disorders,

10–11

World Health Organization (WHO)

approach to hypersexual disorder,

xi

approval of inclusion of CSBD in ICD-11,

10–11

WSAST

. See Women’s Sexual Addiction Screening Test